PHIA Koninklijke Philips N.V.

Philips teams with University of Kentucky's UK HealthCare to power state’s only eICU Clinical Command Center

Philips teams with University of Kentucky's UK HealthCare to power state’s only eICU Clinical Command Center

April 15, 2020

  • Academic medical center leverages Philips tele-ICU technology to enhance clinician experience and help improve outcomes for ICU patients in Kentucky
  • Application of virtual monitoring will help aid University of Kentucky (UK) Healthcare’s teams in care provision for COVID-19 patients

Amsterdam, the Netherlands and Lexington, KY, U.S. – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and , today announced a collaboration to create Kentucky’s only operating clinical command center for tele-critical care and operational optimization. Leveraging , the academic medical center is implementing a centralized virtual care model to help providers detect risk of patient deterioration so they can intervene earlier and help improve care outcomes for the organization’s sickest patients.

Philips’ eICU Program is built around , which uses advanced analytics and AI to synthesize patient data and deliver actionable insights to support proactive care. Using this comprehensive system, University of Kentucky (UK) HealthCare will provide 24/7 remote monitoring and access to specialists for patients in the neurological, trauma, surgery, post-anesthesia care, medical intensive care, emergency department and cardiovascular patient care venues. The institution also aims to improve bed utilization and patient flow across its 160 ICU beds at two hospitals.

Since COVID-19 is predominantly a respiratory illness, patients with more severe cases may require ICU care. eCareManager acuity based scoring tools monitor a patient’s condition to detect subtle deteriorations prior to becoming adverse events. Predictive AI-enabled algorithms such as , designed to focus on a patients cardiovascular and Respiratory systems, provide clinicians in the telehealth center with predictive insights into those patients with the highest probability of requiring an intervention in the next 60 minutes. As bed availability and critical decisions on patient throughput are required, eCareManager integrates as part of its Clinical Performance Applications Suite the , a predictive algorithm that provides clinicians objective scoring on a patients risk of death or readmission within 48 hours of a planned discharge.

“In these most challenging times, healthcare organizations need digital technology to enhance the patient experience, improve health outcomes, lower the cost of care, and enhance the work-life of care providers now more than ever before,” said , Chief Business Leader Connected Care, member of the Executive Committee at Royal Philips. “Partnering with UK HealthCare to address these concerns for the sickest patients demonstrates Philips’ commitment to deliver unique approaches to help meet the demand of healthcare’s greatest challenges.”

“This partnership is vital to our foundational vision of high value care.  Leveraging technology and highly developed clinical algorithms will aid our progressive high-performance health system,” said Dr. Colleen Swartz, Vice President for Hospital Operations at UK HealthCare. “Especially during this time of increased need for very specific isolation and care models in managing COVID-19 patients, the application of virtual monitoring will aid our teams in care provision. Philips is an essential partner in our efforts to progress care across the state.”

First of its kind outcomes-based partnership

As the shift to value-based care and reimbursement is increasingly dependent upon measurable outcomes, Philips and UK HealthCare plan to measure Key Performance Indicator metrics and will work together to identify improvement areas and generate mutual value. The partnership between UK HealthCare and Philips is a pioneering model in ICU telehealth, focused on addressing the quadruple aim by measuring outcomes across both clinical and operational value. The Philips eICU Program is uniquely positioned to partner with customers on innovative outcomes-based models in acute care. With the goal of improving patient care, clinical efficiencies, and ICU quality best practices through telehealth, eICU Program outcomes are demonstrated in peer reviewed publications.

As health systems seek to improve health outcomes, eICU programs enable a co-located team of intensivists and critical care nurses to remotely monitor patients in the ICU regardless of patient location, helping to optimize care costs and enhance clinician and patient satisfaction. Intensivists and nurses based in a telehealth eICU hub are supported by high-definition cameras and communications technology, predictive analytics, data visualization and advanced reporting capabilities to support their frontline colleagues.

Dashboards bring together data from the EMR and patient monitors on the ICU floor, where advanced algorithms alert to signs of deterioration helping the care team to proactively intervene at an earlier stage. eICU programs have been the subject of peer-reviewed literature since 2002, with outcomes data presenting clinical benefits in mortality reduction and operational systems benefits through increased throughput of ICU patients by reducing ICU patient length of stay [1].

Philips is the global leader in centralized tele-critical care. More than 20% of US adult ICU beds and 1 in 8 adult ICU patients are monitored by a 24/7 continuous demand model powered by the eICU Program, which combines A/V technology, predictive analytics, data visualization and advanced reporting capabilities [2, 3]. The core of this program is Philips eCareManager software, which delivers need-to-know information to caregivers, empowering them to care for the patients in a more proactive manner.

platforms are available around the globe with clinical informatics applications supporting bedside, unit and virtual care delivery models. For more information on how Philips is addressing the Coronavirus globally, please visit the .

[1] Lilly CM, et al. A Multi-Center Study of ICU Telemedicine Reengineering of Adult Critical Care. CHEST. 2014 Mar 1; 145(3): 500-7.

[2] Representative of the total Philips eICU licensed beds as a percentage coverage relative to total US adult ICU beds

[3] Derived from SCCM Adult ICU admission statistic and compared to eCareManager eRI annual monitored patients

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail:  

Twitter:

Silvie Casanova

Philips North America

Tel:

E-mail:

Kristi Willett

UK HealthCare PR

Tel.: 859-806-0445

Email:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

About UK HealthCare

is the hospitals and clinics of the University of Kentucky. But it is so much more. It is 9,000 people – physicians, nurses, pharmacists and other healthcare professionals – all dedicated to providing the most advanced, most effective care available, not just in Kentucky but anywhere. UK HealthCare is the power of advanced medicine.



Attachments

EN
15/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for spe...

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments March 4, 2026 CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging a...

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch